| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Ezine Publishing > E-newsletters: Why They're Good for Business |
|
Main Subject - E-newsletters: Why They're Good for Business
WHAT ARE E-NEWSLETTERS? An e-newsletter is a written form of communication that is sent to people by e-mail rather According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product than by more traditional methods like printing. You can use an e-newsletter to tell people about news happening wi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in thin the industry, within your company or any useful information you think that they should know. E-newsletters can lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. be very beneficial to a business for the following 5 reasons: 1. E-newsletters give your company a very low cost here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe method of keeping in touch with key customers and suppliers. Whenever you send it out, people are reminded of your d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro presence and can keep abreast of what is going on within the industry. 2. E-newsletters can establish you as the e ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc xpert in your field. If you’re the one telling them about industry trends and expressing the company’s opinion on t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi hem, this is letting your customers and suppliers know that you have a solid reputation and can be counted on as th nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e ‘expert’. 3. You can use e-newsletters to prompt potential customers to contact you. You can include vouchers, c and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ompetitions or discounts within an e-newsletter, encouraging those that may have been thinking about using your ser ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ices to give you a try. 4. E-newsletters allow you to quickly develop relationships with key suppliers and custome ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a rs. You can for instance let them include articles within your e-newsletter which provides benefits to them (they p dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod romote their business) and benefits to you (you have material for the content of the newsletter). In addition, this cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin also builds up trust and strengthens relationships between you. 5. Finally, e-newsletters are very inexpensive to tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen produce and can quickly reap the benefits outlined above without the expense of printed material. HOW OFTEN SHOUL t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel D E-NEWSLETTERS BE SENT OUT? Many companies send out e-newsletters once a week, but this can often be an overload ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust on time. To start off with, I would recommend that your newsletters should be sent out approximately once a month a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nd that several should be prepared in advance so that you don’t have to think about the content. HOW LONG SHOULD T . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de HEY BE? At first the e-newsletter should be fairly short (1 or 2 pages) so that it is not a lot of work producing elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the content. The length can be increased as you invite customers and suppliers to submit content to your newsletter tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Five Lethal Job-Hunting Mistakes Managers: Don't Write Off Public Relations!
|